365 related articles for article (PubMed ID: 16113242)
1. Isolation of a small molecule inhibitor of DNA base excision repair.
Madhusudan S; Smart F; Shrimpton P; Parsons JL; Gardiner L; Houlbrook S; Talbot DC; Hammonds T; Freemont PA; Sternberg MJ; Dianov GL; Hickson ID
Nucleic Acids Res; 2005; 33(15):4711-24. PubMed ID: 16113242
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zawahir Z; Dayam R; Deng J; Pereira C; Neamati N
J Med Chem; 2009 Jan; 52(1):20-32. PubMed ID: 19072053
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1).
Aiello F; Shabaik Y; Esqueda A; Sanchez TW; Grande F; Garofalo A; Neamati N
ChemMedChem; 2012 Oct; 7(10):1825-39. PubMed ID: 22952012
[TBL] [Abstract][Full Text] [Related]
6. Receptor-based virtual screening and biological characterization of human apurinic/apyrimidinic endonuclease (Ape1) inhibitors.
Ruiz FM; Francis SM; Tintoré M; Ferreira R; Gil-Redondo R; Morreale A; Ortiz ÁR; Eritja R; Fàbrega C
ChemMedChem; 2012 Dec; 7(12):2168-78. PubMed ID: 23109358
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule inhibitors of APE1 DNA repair function: an overview.
Al-Safi RI; Odde S; Shabaik Y; Neamati N
Curr Mol Pharmacol; 2012 Jan; 5(1):14-35. PubMed ID: 22122462
[TBL] [Abstract][Full Text] [Related]
8. Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.
Bapat A; Glass LS; Luo M; Fishel ML; Long EC; Georgiadis MM; Kelley MR
J Pharmacol Exp Ther; 2010 Sep; 334(3):988-98. PubMed ID: 20504914
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
10. Diverse small molecule inhibitors of human apurinic/apyrimidinic endonuclease APE1 identified from a screen of a large public collection.
Dorjsuren D; Kim D; Vyjayanti VN; Maloney DJ; Jadhav A; Wilson DM; Simeonov A
PLoS One; 2012; 7(10):e47974. PubMed ID: 23110144
[TBL] [Abstract][Full Text] [Related]
11. Probing conformational changes in Ape1 during the progression of base excision repair.
Yu E; Gaucher SP; Hadi MZ
Biochemistry; 2010 May; 49(18):3786-96. PubMed ID: 20377204
[TBL] [Abstract][Full Text] [Related]
12. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma brucei AP endonuclease 1 has a major role in the repair of abasic sites and protection against DNA-damaging agents.
Charret KS; Requena CE; Castillo-Acosta VM; Ruiz-Pérez LM; González-Pacanowska D; Vidal AE
DNA Repair (Amst); 2012 Jan; 11(1):53-64. PubMed ID: 22041024
[TBL] [Abstract][Full Text] [Related]
14. The redox function of apurinic/apyrimidinic endonuclease 1 as key modulator in photodynamic therapy.
Franchi LP; de Freitas Lima JEB; Piva HL; Tedesco AC
J Photochem Photobiol B; 2020 Oct; 211():111992. PubMed ID: 32805556
[TBL] [Abstract][Full Text] [Related]
15. New oligonucleotide derivatives as unreactive substrate analogues and potential inhibitors of human apurinic/apyrimidinic endonuclease APE1.
Kuznetsov NA; Kupryushkin MS; Abramova TV; Kuznetsova AA; Miroshnikova AD; Stetsenko DA; Pyshnyi DV; Fedorova OS
Mol Biosyst; 2016 Jan; 12(1):67-75. PubMed ID: 26548492
[TBL] [Abstract][Full Text] [Related]
16. Major oxidative products of cytosine are substrates for the nucleotide incision repair pathway.
Daviet S; Couvé-Privat S; Gros L; Shinozuka K; Ide H; Saparbaev M; Ishchenko AA
DNA Repair (Amst); 2007 Jan; 6(1):8-18. PubMed ID: 16978929
[TBL] [Abstract][Full Text] [Related]
17. Nm23-H1 protein binds to APE1 at AP sites and stimulates AP endonuclease activity following ionizing radiation of the human lung cancer A549 cells.
Zhang ZM; Yang XQ; Wang D; Wang G; Yang ZZ; Qing Y; Yang ZX; Li MX; Xiang DB
Cell Biochem Biophys; 2011 Dec; 61(3):561-72. PubMed ID: 21769563
[TBL] [Abstract][Full Text] [Related]
18. Characterizing inhibitors of human AP endonuclease 1.
Pidugu LS; Servius HW; Sevdalis SE; Cook ME; Varney KM; Pozharski E; Drohat AC
PLoS One; 2023; 18(1):e0280526. PubMed ID: 36652434
[TBL] [Abstract][Full Text] [Related]
19. A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents.
McNeill DR; Wilson DM
Mol Cancer Res; 2007 Jan; 5(1):61-70. PubMed ID: 17259346
[TBL] [Abstract][Full Text] [Related]
20. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Kaur G; Cholia RP; Mantha AK; Kumar R
J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
